SCHEMBL26633985

SCHEMBL26633985

Cc1cnc2cc(C=CS(C)(=O)=O)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
CCR1 P32246 2/20 0.40
CCR5 P51681 2/20 0.40
CCR8 P51685 2/20 0.40
OGA O60502 1/20 0.33
PTGES2 Q9H7Z7 1/20 0.33
TGFBR1 P36897 1/20 0.33
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPC1 O15118 1/20 0.32
HPGD P15428 1/20 0.32
NFKB1 P19838 1/20 0.32
RAB9A P51151 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ALPL P05186 1/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633977 1.00 CYP1A2 (0.44) CYP1A2CCR1CCR5CCR8OGA
SCHEMBL9970469 0.80 CYP1A2 (0.50) CYP1A2CCR1CCR5CCR8OGA
SCHEMBL26787865 0.79 CYP1A2 (0.46) CYP1A2CCR1CCR5CCR8OGA
SCHEMBL12248132 0.77 CYP1A2 (0.47) CYP1A2CCR1CCR5CCR8OGA
SCHEMBL13167636 0.77 CYP1A2 (0.47) CYP1A2CCR1CCR5CCR8OGA
SCHEMBL26634020 0.77 RAB9A (0.55) CYP1A2KDM4EALDH1A1SMN1; SMN2HPGD
SCHEMBL26634019 0.77 CYP1A2 (0.44) CYP1A2CCR1CCR5CCR8OGA
SCHEMBL26634011 0.77 CYP1A2 (0.44) CYP1A2CCR1CCR5CCR8OGA
SCHEMBL10031854 0.76 PDGFRB (0.47) CYP1A2CCR1CCR5CCR8KDM4E
SCHEMBL26633989 0.75 CYP1A2 (0.42) CYP1A2CCR1CCR5CCR8OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270187-A1 MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY THE SCRIPPS RESEARCH INSTITUTE 2025-08-28 US disclosed
WO-2023212565-A2 MOLECULAR EDITING OF MULTIPLE C-H BONDS BY LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY THE SCRIPPS RESEARCH INSTITUTE (US) 2023-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270187-A1 MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY CYCS, CYC1, CDA CYP1A2 157/4885CCR1 545/4885CCR5 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.